In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for Hypercholesterolemia

Scott B. Vafai

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Jörg Täubel

Richmond Pharmacology, London

Thomas Ashdown

Richmond Pharmacology, London

Riyaz S. Patel

Institute of Cardiovascular Science, University College London, London

Sadaf Diamondali

Barts Health NHS Trust, London

Jaimini Cegla

Imperial College London, London

Handrean Soran

National Institute for Health and Care Research–Wellcome Trust Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, United Kingdom

Bilal Bashir

National Institute for Health and Care Research–Wellcome Trust Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, United Kingdom

Alexander Abitbol

LMC Diabetes and Endocrinology, Toronto

Daniel Gaudet

Department of Medicine, Université de Montréal, Montreal

Alex Lauzière

Department of Medicine, Université de Montréal, Montreal

Liam R. Brunham

Department of Medicine, University of British Columbia, Vancouver, Canada

David E. Newby

British Heart Foundation Centre for Research Excellence, University of Edinburgh, Edinburgh

Stephen J. Nicholls

Victorian Heart Institute, Monash University, Melbourne, VIC, Australia

Russell S. Scott

New Zealand Clinical Research, Christchurch, New Zealand

Jane Kerr

New Zealand Clinical Research, Christchurch, New Zealand

Jean-Claude Tardif

Montreal Heart Institute, Université de Montréal, Montreal

Catherine Lunken

University College London Hospitals NHS Foundation Trust, London

Steve E. Humphries

Institute of Cardiovascular Science, University College London, London

Verena Karsten

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Patrick D. Tyler

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Xinyan Zhang

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Nidal Huniti

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Patrick A. Flight

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Chelsey L. Jensen

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Rick Falzone

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Joseph C. Biedenkapp

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Troy Lister

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Leslie E. Stolz

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Amit V. Khera

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Sekar Kathiresan

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston